Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Gains from Sales and Divestitures (2016 - 2017)

Ocugen (OCGN) has disclosed Gains from Sales and Divestitures for 3 consecutive years, with $1889.0 as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Gains from Sales and Divestitures fell 42.77% year-over-year to $1889.0, compared with a TTM value of $1889.0 through Dec 2017, down 42.77%, and an annual FY2017 reading of $1889.0, down 42.77% over the prior year.
  • Gains from Sales and Divestitures was $1889.0 for Q4 2017 at Ocugen, roughly flat from $1889.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $3303.0 in Q4 2015 and bottomed at $1889.0 in Q2 2015.
  • Average Gains from Sales and Divestitures over 3 years is $2203.0, with a median of $1889.0 recorded in 2015.
  • The sharpest move saw Gains from Sales and Divestitures changed 0.0% in 2016, then tumbled 42.77% in 2017.
  • Year by year, Gains from Sales and Divestitures stood at $3303.0 in 2015, then decreased by 0.06% to $3301.0 in 2016, then plummeted by 42.77% to $1889.0 in 2017.
  • Business Quant data shows Gains from Sales and Divestitures for OCGN at $1889.0 in Q4 2017, $1889.0 in Q3 2017, and $1889.0 in Q2 2017.